NKDEP has released a report summarizing the burden of CKD, NKDEP’s efforts to address CKD disparities and improve care, and the program’s future directions. The report titled, "National Kidney Disease Education Program: Reducing Disparities, Improving Care - A Summary Report," organizes NKDEP's initiatives by the Chronic Care Model, the program’s guiding principle. The report is available to view or order on NKDEP’s website.
Since its inception, NKDEP has encouraged the use of estimated GFR to detect and monitor chronic kidney disease (CKD). Over the past few years, we have expanded our focus to include the urine albumin test, which is critical to not only detecting CKD, but also to assessing response to therapy. To help providers explain the two tests for CKD, NKDEP has recently updated its popular GFR tear-off pad to include a section on urine albumin test results. Explaining Your Kidney Tests Results Tear-off Pad for Clinical Use provides a simple narrative and a graphical explanation of urine albumin and GFR. Download the new tool now!
NKDEP continually strives to communicate key messages as clearly and simply as possible, particularly for those at risk for CKD. One of our most recent efforts involved a revision of Make the Kidney Connection brochure, which is now titled, For People with Diabetes or High Blood Pressure: Get Checked for Kidney Disease. The 4-panel brochure explains why people with diabetes or high blood pressure should be tested for CKD, how the kidneys are tested, and the steps one can take to protect the kidneys.
In October, we told you about our new web videos which aim to foster productive patient-provider interactions about CKD and risk, treatment, testing and diagnosis, and dialysis and transplantation. If you educate patients about CKD, please view one or more of our 16 video clips. Then tell us what you think by clicking on the video page’s highlight button or taking the quick survey.
NKDEP has developed Chronic Kidney Disease and Drug Dosing: Information for Providers, an educational statement that provides guidance on drug dosing in the post-creatinine standardization environment. The statement addresses:
On January 1, 2010, Section 152(b) of the Medicare Improvements for Patients and Providers Act (MIPPA) added kidney disease education (KDE) services as a Medicare Part B covered benefit. The benefit is designed to provide Medicare beneficiaries diagnosed with stage four CKD with comprehensive information regarding the management of comorbidities, prevention of uremic complications, and options for renal replacement therapy. KDE services must be furnished by a qualified person, which includes a physician, physician assistant, nurse practitioner, or clinical nurse specialist. In addition, providers of services that are located in rural areas can also furnish KDE services.
The final rule, which was published in the Federal Register on November 25, 2009, specifies beneficiary eligibility, session specifications, standards for content, and the development of outcomes assessments. The regulation can be found at 42 CFR 410.48. For additional information about the new KDE benefit, please contact Jamie Hermansen.
Patients now have access to encyclopedic health information on the go. NLM is pleased to announce the launch of Mobile MedlinePlus, a streamlined, mobile resource featuring a subset of the trusted information from the main MedlinePlus website. Both English and Spanish versions of the site are available. Among the information provided are:
Please share this with your colleagues and patients, and be sure to send your feedback using the Contact Us link at the bottom of any Mobile MedlinePlus page. You can also send your comments directly to Loren Frant.
The National Institutes of Health (NIH) is the primary Federal agency for conducting and supporting medical research. NIH-funded studies help determine causes, treatments, and even cures for diseases. To improve the quality and transparency of proposal review, the NIH Peer Review Initiative is changing the grant application process. For research proposals due on or after January 25, 2010, applicants must follow updated instructions and submit a restructured application form. One of the main changes will be significantly shorter page limits. Old application forms will no longer be reviewed. Visit the Enhancing Peer Review website to read more about the restructured process.
CMS is convening a Technical Expert Panel (TEP) for the development of new quality measures for the ESRD population on March 10-11, 2010. Nominations as well self-nominations for this TEP are now being accepted through February 17 at CMS’s Call for Technical Expert Panel website.
This TEP will be unique in that CMS will be convening Six Clinical TEPs of approximately six to eight individuals each that will evaluate evidence for the development of new measures based on the following topic areas:
In order to develop the strongest quality measures, CMS is seeking experts with the following qualifications: Topic knowledge; expertise including, but not limited to: ESRD, anemia management, mineral metabolism, vascular access infection rate, pediatric adequacy, pediatric anemia and fluid weight management; performance measurement; quality improvement; consumer perspective; purchaser perspective; health care disparities. For more information, click here.
Page last updated: March 1, 2012